Background Magnetic nanoparticles (NPs) loaded with antitumor drugs in combination with an external magnetic field (EMF)-guided delivery can improve the efficacy of treatment and may decrease serious side effects. The purpose of this study was 1) to investigate application of PEG modified GMNPs (PGMNPs) as a drug carrier of the chemotherapy compound doxorubicin (DOX) in vitro; 2) to evaluate the therapeutic efficiency of DOX-conjugated PGMNPs (DOX-PGMNPs) using an EMF-guided delivery in vivo. Methods First, DOX-PGMNPs were synthesized and the cytotoxicity of DOX-PGMNPs was assessed in vitro. Second, upon intravenous administration of DOX-PMGPNs to H22 hepatoma cell tumor-bearing mice, the DOX biodistribution in different organs (tissues) was measured. The antitumor activity was evaluated using different treatment strategies such as DOX-PMGPNs or DOX-PMGPNs with an EMF-guided delivery (DOX-PGMNPs-M). Results The relative tumor volumes in DOX-PGMNPs-M, DOX-PGMNPs, and DOX groups were 5.46±1.48, 9.22±1.51, and 14.8±1.64, respectively (each p<0.05), following treatment for 33 days. The life span of tumor-bearing mice treated with DOX-PGMNPs-M, DOX-PGMNPs, and DOX were 74.8±9.95, 66.1±13.5, and 31.3±3.31 days, respectively (each p<0.05). Conclusion This simple and adaptive nanoparticle design may accommodate chemotherapy for drug delivery optimization and in vivo drug-target definition in system biology profiling, increasing the margin of safety in treatment of cancers in the near future.
References
[1]
Mejias R, Perez-Yague S, Gutierrez L, Cabrera LI, Spada R, et al. (2011) Dimercaptosuccinic acid-coated magnetite nanoparticles for magnetically guided in vivo delivery of interferon gamma for cancer immunotherapy. Biomaterials 32 (11) 2938–2952.
[2]
Sanson C, Diou O, Thevenot J, Ibarboure E, Soum A, et al. (2011) Doxorubicin Loaded Magnetic Polymersomes: Theranostic Nanocarriers for MR Imaging and Magneto-Chemotherapy. ACS Nano 5 (2) 1122–40.
[3]
Jain KK (2010) Advances in the field of nanooncology. BMC Med 8: 83.
[4]
Singh A, Dilnawaz F, Mewar S, Sharma U, Jagannathan NR, et al. (2011) Composite polymeric magnetic nanoparticles for co-delivery of hydrophobic and hydrophilic anticancer drugs and MRI imaging for cancer therapy. ACS Appl Mater Interfaces 3 (3) 842–856.
[5]
Yang XQ, Hong H, Grailer JJ, Rowland IJ, Javadi A, et al. (2011) cRGD-functionalized, DOX-conjugated, and (64)Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging. Biomaterials 32: 4151–4160.
[6]
Qian X, Peng XH, Ansari DO, Yin-Goen Q, Chen GZ, et al. (2008) In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nat Biotechnol 26 (1) 83–90.
[7]
Gibson JD, Khanal BP, Zubarev ER (2007) Paclitaxel-Functionalized Gold Nanoparticles. J Am Chem Soc 129: 11653–11661.
[8]
Zharov VP, Letfullin RR, Galitovskaya EN (2005) Microbubbles-overlapping mode for laser killing of cancer cells with absorbing nanoparticle clusters. J Phys DAppl Phys 38: 2571–2581.
[9]
Gupta AK, Gupta M (2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26: 3995–4021.
[10]
Lin J, Zhou WL, Kumbhar A, Wiemann J, Fang JY, et al. (2001) Gold-coated iron (Fe@Au) nanoparticles: synthesis, characterization, and magnetic field-induced selfassembly. J Solid State Chem 159: 26–31.
[11]
Kim J, Park S, Lee JE, Jin SM, Lee JH, et al. (2006) Designed Fabrication of Multifunctional Magnetic Gold Nanoshells and Their Application to Magnetic Resonance Imaging and Photothermal Therapy. Angew Chem Int Ed 45: 7754–7758.
[12]
Chao X, Guo LL, ZhaoYY, Hua K, Peng ML, et al. (2011) PEG-modified GoldMag nanoparticles (PGMNs) combined with the magnetic field for local drug delivery. J Drug Target 19 (3) 161–170.
[13]
Chao X, Shi F, Zhao YY, Li K, Peng ML, et al. (2010) Cytotoxicity of Fe3O4/Au composite nanoparticles loaded with doxorubicin combined with magnetic field. Pharmazie 65 (7) 500–504.
[14]
Li Z, Jian L, Wang H, Cui Y (2007) Flow injection chemiluminescent determination of clenbuterol using GoldMag particles as carrier. Food Addit Contam 24 (1) 21–25.
[15]
Zhao X, Cai Y, Wang T, Shi Y, Jiang G (2008) Preparation of alkanethiolate-functionalized core/shell Fe3O4@Au nanoparticles and its interaction with several typical target molecules. Anal Chem 80 (23) 9091–9096.
[16]
Cui YL, Wang Y, Hui WL, Zhang Z, Xin X, et al. (2005) The synthesis of GoldMag nano-particles and their application for antibody immobilization. Biomed Microdevices 7 (2) 153–156.
[17]
Shubayev VI, Pisanic TRII, Jin S (2009) Magnetic nanoparticles for theragnostics. Adv Drug Deliv Rev 61 (6) 467–477.
[18]
Zamboni WC (2008) Concept and clinical evaluation of carrier-mediated anticancer agents. Oncologist 13 (3) 248–260.
[19]
Kuruppuachchi M, Savoie H, Lowry A, Boyle RW (2011) Polyacrylamide Nanoparticles as a Delivery System in Photodynamic Therapy. Mol Pharm 8: 920–931.
[20]
Meng Y, Zou C, Madiyalakan R, Woo T, Huang M, et al. (2010) Water-soluble and biocompatible sono/photosensitizer nanoparticles for enhanced cancer therapy. Nanomedicine 5 (10) 1559–1569.
[21]
Huynh NT, Roger E, Lautram N, Benoit JP, Passirani C (2010) The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting. Nanomedicine 5 (9) 1415–1433.
[22]
Shukla S, Wu G, Chatterjee M, Yang W, Sekido M, et al. (2003) Synthesis and biological evaluation of folate receptor-targeted boronated PAMAM dendrimers as potential agents for neutron capture therapy. Bioconjug Chem 14 (1) 158–167.
[23]
Kim D, Park S, Lee JH, Jeong YY, Jon S (2007) Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging. J Am Chem Soc 129: 7661–7665.
[24]
Carr BI (2004) Hepatocellular carcinoma: current management and future trends. Gastroenterology 127: 218–224.
[25]
Paciotti GF, Myer L, Weinreich D, Goia D, Pavel N, et al. (2004) Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv 11 (3) 169–183.
[26]
Gupta AK, Gupta M (2005) Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles. Biomaterials 26 (13) 1565–1573.
[27]
Huang X, Li B, Zhang H, Hussain I, Liang L, et al. (2011) Facile preparation of size-controlled gold nanoparticles using versatile and end-functionalized thioether polymer ligands. Nanoscale 3 (4) 1600–1607.
[28]
Lee W, Cho NJ, Xiong A, Glenn JS, Frank CW (2010) Hydrophobic nanoparticles improve permeability of cell-encapsulating poly(ethylene glycol) hydrogels while maintaining patternability. Proc Natl Acad Sci 107 (48) 20709–20714.
[29]
Cho WS, Cho M, Jeong J, Choi M, Han BS, et al. (2010) Size-dependent tissue kinetics of PEG-coated gold nanoparticles. Toxicol Appl Pharmacol 245 (1) 116–123.
[30]
Cho WS, Cho M, Jeong J, Choi M, Han BS, et al. (2009) Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Toxicol Appl Pharmacol 236 (1) 16–24.
[31]
Lencioni R (2010) Loco-regional treatment of hepatocellular carcinoma in the era of molecular targeted therapies. Hepatology 52 (2) 762–773.
[32]
Bajaj G, Yeo Y (2010) Drug delivery systems for intraperitoneal therapy. Pharm Res 27 (5) 735–738.
